Australia markets closed

Ever Supreme Bio Technology Co., Ltd (6712.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
208.00-1.50 (-0.72%)
At close: 01:30PM CST
Currency in TWD

Valuation measures4

Market cap (intra-day) 15.36B
Enterprise value 14.04B
Trailing P/E 29.02
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)20.65
Price/book (mrq)8.34
Enterprise value/revenue 18.51
Enterprise value/EBITDA 21.41

Trading information

Stock price history

Beta (5Y monthly) 0.33
52-week change 33.31%
S&P500 52-week change 323.57%
52-week high 3229.00
52-week low 3170.00
50-day moving average 3210.80
200-day moving average 3199.78

Share statistics

Avg vol (3-month) 3730.31k
Avg vol (10-day) 3543.1k
Shares outstanding 573.34M
Implied shares outstanding 674.99M
Float 854.04M
% held by insiders 133.06%
% held by institutions 12.14%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.99
Forward annual dividend yield 40.95%
Trailing annual dividend rate 33.50
Trailing annual dividend yield 31.67%
5-year average dividend yield 4N/A
Payout ratio 427.60%
Dividend date 3N/A
Ex-dividend date 429 May 2023
Last split factor 21099.649:1000
Last split date 329 May 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 71.12%
Operating margin (ttm)52.51%

Management effectiveness

Return on assets (ttm)10.42%
Return on equity (ttm)29.68%

Income statement

Revenue (ttm)758.39M
Revenue per share (ttm)10.18
Quarterly revenue growth (yoy)41.90%
Gross profit (ttm)N/A
EBITDA 357.69M
Net income avi to common (ttm)539.4M
Diluted EPS (ttm)7.23
Quarterly earnings growth (yoy)-24.60%

Balance sheet

Total cash (mrq)1.34B
Total cash per share (mrq)18.2
Total debt (mrq)5.9M
Total debt/equity (mrq)0.32%
Current ratio (mrq)6.57
Book value per share (mrq)25.13

Cash flow statement

Operating cash flow (ttm)421.74M
Levered free cash flow (ttm)304.48M